Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorState University of New York at Buffalo

About this trial

The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.

Eligibility criteria

Qualifiers

Subjects with known, or suspected risk factors for steatosis (fat) or hepatic fibrosis

Subjects who have been previously diagnosed with Non-Alcoholic Steatohepatitis (NASH) but who do not have current steatosis (fat) or fibrosis scoring

Subjects who have other known liver diseases ie: HCV

Disqualifiers

Patients less than 18 years of age

Pregnancy

Patients that do not want to be contacted for consideration in future research studies.

Patients diagnosed with ascites or peritoneal dialysis

Trial design

Treatments tested in this trial

  • vibration controlled transient elastography (VCTE)

Treatment groups

1,000 Participants
are divided into 1 treatment group

Sponsors and collaborators